[Ovid] Improving Executive Function and Dual-Task Cost in Parkinson Disease: A Randomized Controlled Trial |
|
This post will be closed automatically in 2026-07-01 11:09
Reward10points
|
| |
10
OCE-205, a selective V1a receptor mixed agonist每antagonist, for the treatment of hepatorenal syndrome每acute kidney injury: A phase 2 randomized trial
10
Segmented and sectional orthodontic technique: Review and case report
10
Development and Psychometric Evaluation of Nurses＊ Ethical Acceptance of Artificial Intelligence Scale in Clinical Practice
10
GLP-1 receptor agonist每SGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes
10
Hepatocyte CEBPA-ORM1 axis restricts alcohol-associated liver disease
